WO2005084648A8 - Compositions pharmaceutiques comprenant du candesartan cilexetil - Google Patents

Compositions pharmaceutiques comprenant du candesartan cilexetil

Info

Publication number
WO2005084648A8
WO2005084648A8 PCT/IB2005/000494 IB2005000494W WO2005084648A8 WO 2005084648 A8 WO2005084648 A8 WO 2005084648A8 IB 2005000494 W IB2005000494 W IB 2005000494W WO 2005084648 A8 WO2005084648 A8 WO 2005084648A8
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical compositions
candesartan cilexetil
cilexetil
candesartan
processes
Prior art date
Application number
PCT/IB2005/000494
Other languages
English (en)
Other versions
WO2005084648A1 (fr
Inventor
Romi Barat Singh
Girish Karanth
Vishnubhotla Naga Prasad
Original Assignee
Ranbaxy Lab Ltd
Romi Barat Singh
Girish Karanth
Vishnubhotla Naga Prasad
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd, Romi Barat Singh, Girish Karanth, Vishnubhotla Naga Prasad filed Critical Ranbaxy Lab Ltd
Publication of WO2005084648A1 publication Critical patent/WO2005084648A1/fr
Publication of WO2005084648A8 publication Critical patent/WO2005084648A8/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des compositions pharmaceutiques orales stables comprenant du candésartan cilexetil et un polymère soluble dans l'eau, ainsi que des procédés de préparation desdites compositions.
PCT/IB2005/000494 2004-02-27 2005-02-25 Compositions pharmaceutiques comprenant du candesartan cilexetil WO2005084648A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN308DE2004 2004-02-27
IN308/DEL/2004 2004-02-27

Publications (2)

Publication Number Publication Date
WO2005084648A1 WO2005084648A1 (fr) 2005-09-15
WO2005084648A8 true WO2005084648A8 (fr) 2005-12-15

Family

ID=34917508

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2005/000494 WO2005084648A1 (fr) 2004-02-27 2005-02-25 Compositions pharmaceutiques comprenant du candesartan cilexetil

Country Status (1)

Country Link
WO (1) WO2005084648A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI494134B (zh) * 2006-06-20 2015-08-01 Siegfried Generics Int Ag 含有坎地沙坦酯的組成物、錠劑和顆粒及該錠劑的製造方法
WO2008045006A1 (fr) * 2006-10-11 2008-04-17 Fako Ilaclari A. S. Formulations de candésartan
WO2008068727A2 (fr) * 2006-12-06 2008-06-12 Ranbaxy Laboratories Limited Composition pharmaceutique comprenant du candésartan cilexétil
EP1952806A1 (fr) 2007-02-01 2008-08-06 Helm AG Procédé de préparation des produits d'absorption de candesartan
PL384680A1 (pl) * 2007-03-28 2008-09-29 Zak & Lstrok Ady Farmaceutyczn Kompozycja farmaceutyczna zawierająca kandesartan cyleksetylu oraz sposób jej wytwarzania
EP2050440A1 (fr) * 2007-10-18 2009-04-22 Krka Composition pharmaceutique solide stable comprenant du candesartan ou ses formes pharmaceutiquement acceptables
WO2009013237A2 (fr) * 2007-07-20 2009-01-29 Krka, D.D. Novo Mesto Composition pharmaceutique solide stable comprenant du candesartan ou ses formes pharmaceutiquement acceptables
DE102007052070A1 (de) 2007-10-30 2009-05-07 Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg Candesartancilexetil
ATE533474T1 (de) 2008-09-17 2011-12-15 Helm Ag Durch nassgranulation hergestellte stabile und fertig gelöste zusammensetzungen aus candesartan- cilexetil
DE102008059206A1 (de) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
ES2364011B1 (es) 2009-11-20 2013-01-24 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados para el tratamiento de enfermedades cardiovasculares.
CZ302789B6 (cs) * 2009-11-25 2011-11-09 Zentiva, K. S. Zpusob zvýšení rozpustnosti farmaceuticky aktivních látek a cílený (kontrolovaný) transport do streva
MX2014013320A (es) 2012-05-07 2015-08-10 Bayer Pharma AG Procedimiento de fabricacion de una forma de dosificacion farmaceutica que comprende nifedipina y candesartan cilexetilo.
KR101710441B1 (ko) 2015-12-28 2017-02-28 신풍제약주식회사 안정성 및 용출성이 향상된 정제

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1123342C (zh) * 1997-10-17 2003-10-08 欧洲基因有限公司 肾素－血管紧张素系统的抑制剂的用途
AR019935A1 (es) * 1998-07-28 2002-03-27 Takeda Pharmaceutical Preparacion solida de desintegracion rapida, uso de una hidroxipropil celulosa poco sustituida en dicha preparacion y metodo para mejorar la capacidad dedesintegracion rapida de la misma
AU2001284413A1 (en) * 2000-08-30 2002-03-13 Sankyo Company Limited Medicinal compositions for preventing or treating heart failure

Also Published As

Publication number Publication date
WO2005084648A1 (fr) 2005-09-15

Similar Documents

Publication Publication Date Title
WO2005084648A8 (fr) Compositions pharmaceutiques comprenant du candesartan cilexetil
WO2005079751A3 (fr) Compositions pharmaceutiques orales de candesartan cilexetil
WO2008006528A3 (fr) Nouvelles compositions pharmaceutiques comprenant du lévétiracétam
WO2007019439A3 (fr) Compositions de copolymere sequence et utilisations de ces dernieres
IL228402A0 (en) Nitro-cyclic compounds, their pharmaceutical preparations and their uses
IL180115A0 (en) A conjugate of a factor ix moiety and a polymer, compositions containing the same and methods for the preparation thereof
WO2006127941A3 (fr) Hydrochlorure de cinacalcet amorphe et sa preparation
IL181301A0 (en) Cyclopamine analogues, pharmaceutical compositions comprising them and uses thereof
IL181618A0 (en) Pharmaceutical solid-in-oil compositions for external administraton, methods for preparation and uses thereof
IL229304A (en) Compounds 1 ', 3' - Imaging Converts - 4 - Phenyl - 3, 4, 5, 6 - Tetrahydro - 2h, 1'h, [1, 4 '] Bipyridinyl - 2' - lozenges, pharmaceutical preparations containing them and their use
ZA200805011B (en) Water-soluble benzoazepine compound and its pharmaceutical composition
SI2033629T1 (sl) Trden farmacevtski sestavek, ki obsega valsartan
WO2006056696A3 (fr) 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
WO2009068708A3 (fr) Composition pharmaceutique à libération prolongée de somatostatine ou d'un analogue de celle-ci
IL181022A0 (en) Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical compositions comprising the same
WO2007083190A8 (fr) Extrait d'helychrisum insoluble dans l'eau, et procédés d'élaboration et d'utilisation correspondants
ATE479427T1 (de) Pharmazeutische zusammensetzung mit candesartan- cilexetil
ZA200705131B (en) Solid pharmaceutical composition comprising valsartan
PT1791872E (pt) Hexadecassacáridos biotinilados, composições farmacêuticas e sua utilização
WO2008060546A3 (fr) Formulations orales
WO2007099555A3 (fr) Compositions pharmaceutiques contenant de l'irbésartan
IL192824A (en) Peptide compounds, pharmaceuticals containing them and their use
WO2005123721A3 (fr) Formes amorphes et polymorphes de candesartan cilexetil
WO2009060064A3 (fr) Formulations pharmaceutiques pour l'administration par voie orale de ppi
WO2006005578A3 (fr) Composition pharmaceutique solide comprenant de la mirtazapine

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 37/2005 UNDER (74) REPLACE "C/O DESHMUCK, JAY, R." BY "C/O DESHMUKH, JAY, R."

122 Ep: pct app. not ent. europ. phase